S
Stockadora

Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 1175 Events
🤖 AI Analyzed
Recent
📄 Page 67 of 98
NOODLES & Co
8-K December 29, 2025

Key Highlights

  • Noodles & Company received a delisting notice from Nasdaq on December 23, 2025, ...
  • The company plans to request a hearing with Nasdaq by December 30, 2025, to pres...
  • Stockholders will vote on February 4, 2026, to authorize the Board of Directors ...
Read Analysis
🤖 AI Generated
CVR ENERGY INC
8-K December 29, 2025

Key Highlights

  • Mark A. Pytosh has been appointed as the new President and Chief Executive Offic...
  • Mr. Pytosh will replace David L. Lamp, who is stepping down from the CEO role on...
  • Mr. Pytosh will also join the CVR Energy Board of Directors, increasing the boar...
Read Analysis
🤖 AI Generated
lululemon athletica inc.
8-K December 29, 2025

Key Highlights

  • Lululemon founder Dennis J. Wilson intends to nominate his own candidates to the...
  • Wilson also proposes to 'declassify' the board, which would make all directors s...
  • Lululemon issued a press release in response to Wilson's actions.
Read Analysis
🤖 AI Generated
EchoStar CORP
8-K December 29, 2025

Key Highlights

  • EchoStar CORP formalized the employment terms for its Chief Executive Officer, H...
  • The new agreement, effective December 26, 2025, outlines his compensation and be...
  • The agreement clarifies the financial arrangements for the CEO, signaling leader...
Read Analysis
🤖 AI Generated
Verisk Analytics, Inc.
8-K December 29, 2025

Key Highlights

  • Verisk divested its Energy and Specialized Markets (ESM) division for approximat...
  • The company terminated a planned acquisition of ExactLogix, Inc. (AccuLynx.com) ...
  • Following the failed acquisition, Verisk terminated a $750 million loan facility...
Read Analysis
🤖 AI Generated
Vivakor, Inc.
8-K December 29, 2025

Key Highlights

  • Vivakor, Inc.'s stock is being delisted from the Nasdaq stock exchange, and trad...
  • The delisting is due to the company's stock price falling below Nasdaq's $1.00 m...
  • This event is a significant blow to Vivakor's reputation and its ability to attr...
Read Analysis
🤖 AI Generated
Arcadia Biosciences, Inc.
8-K December 29, 2025

Key Highlights

  • Arcadia Biosciences' planned merger with Roosevelt Resources, LP has been termin...
  • Roosevelt Resources terminated the agreement because the merger did not close by...
  • Arcadia Biosciences will now remain an independent company, significantly alteri...
Read Analysis
🤖 AI Generated
Silo Pharma, Inc.
8-K December 29, 2025

Key Highlights

  • Silo Pharma, Inc. received an extension from Nasdaq to regain compliance with th...
  • The new deadline for the company to meet the listing requirement is June 22, 202...
  • Staying listed on Nasdaq is crucial for the company's credibility, investor attr...
Read Analysis
🤖 AI Generated
Ultragenyx Pharmaceutical Inc.
8-K December 29, 2025

Key Highlights

  • Ultragenyx's experimental drug setrusumab (UX143) failed to meet its primary goa...
  • The drug did not significantly reduce bone fractures, which was its main objecti...
  • As a direct consequence of the trial results, the company is planning 'significa...
Read Analysis
🤖 AI Generated
Clearside Biomedical, Inc.
8-K December 29, 2025

Key Highlights

  • Clearside Biomedical, Inc. has filed for Chapter 11 bankruptcy due to serious fi...
  • The company is reorganizing under court supervision and plans to sell off all or...
  • A 'Stalking Horse Bidder' (Health Ocean Limited) has made an initial bid, and an...
Read Analysis
🤖 AI Generated
Mereo BioPharma Group plc
8-K December 29, 2025

Key Highlights

  • Mereo BioPharma announced results from two Phase 3 clinical trials (Orbit and Co...
  • Setrusumab significantly improved bone mineral density (BMD) in patients.
  • The drug did not statistically reduce the number of fractures, which was the pri...
Read Analysis
🤖 AI Generated
Adicet Bio, Inc.
8-K December 29, 2025

Key Highlights

  • Adicet Bio, Inc. announced a 1-for-16 reverse stock split to consolidate shares.
  • The primary goal of the split is to increase the stock price per share to meet N...
  • While the number of shares will decrease and the price per share will increase p...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage